Metallic radionuclides possess a variety of half-lives, emission types, energies, and
branching ratios, making it possible to apply them as diagnostic and/or therapeutic agents …

Bacterial infections have always been, and still are, a major global healthcare problem. For
accurate treatment it is of upmost importance that the location (s), severity, type of bacteria …

COVID-19 pandemic has heightened the interest toward diagnosis and treatment of
infectious diseases. Nuclear medicine with its powerful scintigraphic, single photon emission …

New rhenium (I) tricarbonyl complexes with the quinolone antimicrobial agents oxolinic acid
(Hoxo) and enrofloxacin (Herx) and containing methanol, triphenylphosphine (PPh 3) or …

Infectious diseases caused by bacteria that have become resistant to antibiotics have
increased in prevalence, necessitating new methods for their diagnosis and treatment. The …

The syntheses of non-oxido/non-nitrido bis (thiosemicarbazonato) technetium (V) complexes
featuring a series of alkyl and ether substituents is presented. The bis (thiosemicarbazones) …

This paper presents the application of ciprofloxacin as a biologically active molecule (vector)
for delivering diagnostic radiopharmaceuticals to the sites of bacterial infection …

With an aim of developing a bacteria‐specific molecular imaging agent, ciprofloxacin has
been modified with a propylamine spacer and linked to two common bifunctional chelators …

An important issue in the development of metal-based radiopharmaceuticals is the selection
of the labelling strategy in order to couple the metal to the pharmacophore without losing the …

In nuclear medicine, the detection of inflamed and infected lesions is of growing interest.
Extensive efforts have been made to develop radiopharmaceuticals specific for inflammation …